Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined Poor-Prognostic Cervical Cancer
This study is enrolling participants by invitation only.
Sponsor:
Chang Gung Memorial Hospital
Collaborator:
Eli Lilly and Company
Information provided by:
Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier:
NCT00842660
First received: February 8, 2009
Last updated: January 3, 2010
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is enrolling participants by invitation only. |
|---|---|
| Estimated Study Completion Date: | January 2013 |
| Estimated Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |